Download This Paper
Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early stage research papers that have not been peer-reviewed. The findings should not be used for clinical or public health decision making and should not be presented to a lay audience without highlighting that they are preliminary and have not been peer-reviewed. For more information on this collaboration, see the comments published in The Lancet about the trial period, and our decision to make this a permanent offering, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com.
Comprehensive Characterization of the rRNA Metabolic Related Genes in Human Cancer
48 Pages Posted: 4 Apr 2019
More...Abstract
Background: Although rRNA metabolic related genes have been reported to be associated with human cancer, a systematic assessment of rRNA metabolic related genes across human cancers is lacking. Thus, we perform a pan-cancer analysis of rRNA metabolic related genes across 21 human cancers.
Methods: We performed a pan-cancer analysis for mRNA expression, mutation, DNA methylation, copy number variation (CNV) and clinical relevance of rRNA metabolic related genes in more than 9,000 patients across 21 human cancers from The Cancer Genome Atlas (TCGA) dataset. In addition, ten independent datasets from Gene Expression Omnibus (GEO), Cancer Cell Line Encyclopedia (CCLE) and Project Achilles datasets were used to verify our study.
Findings: The landscape of rRNA metabolic related genes was established across 21 human cancers. The results suggested that rRNA metabolic related genes are upregulated in multiple cancers, particularly in digestive and respiratory system cancers. Most of the upregulated genes are associated with poor prognosis and driven by CNV rather than mutation and DNA hypomethylation. We systematically identified CNV-driven rRNA metabolic related genes with clinical relevance, including EXOSC8. Finally, functional experiments confirmed the oncogenic roles of EXOSC8 in colorectal carcinoma.
Interpretation: Our study highlights the important roles of rRNA metabolic related genes in tumorigenesis as prognostic biomarkers.
Funding: This work was supported by grants from the National Key R&D Program of China (2016YFC1302300) and National Nature Science Foundation of China (81772609, 81802782).
Declaration of Interest: The authors have declared that no competing interests exist.
Ethical Approval: Animal studies were approved by the Animal Care Committee of Wuhan University. AOM-/DSS-induced CRC model and lentivirus administration were performed following the according to the methods previously described.
Keywords: Pan-cancer; ribosomal RNA metabolic process, copy number variation, clinical relevance, EXOSC8
Suggested Citation: Suggested Citation